Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Gujarat Terce Laboratories is engaged in manufacturing of tablets, capsules, and syrup and injection pertaining to the product group pharmaceuticals.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
GUJARAT TERCE LABORATORIES LTD. - 524314 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011 | Download
GUJARAT TERCE LABORATORIES LTD. - 524314 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011 | Download
GUJARAT TERCE LABORATORIES LTD. - 524314 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024 | Download
GUJARAT TERCE LABORATORIES LTD. - 524314 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant